Online Database of Chemicals from Around the World

N-(1-(Phenylacetyl)-L-prolyl)glycine ethyl ester
[CAS 157115-85-0]

List of Suppliers
BOC Sciences USA
www.bocsci.com
+1 (631) 485-4226
+1 (631) 614-7828
info@bocsci.com
Chemical manufacturer
chemBlink Standard supplier since 2010
Shanghai Hohance Chemical Co., Ltd. China
www.hohance.com
+86 (21) 3111-5312
+86 (21) 3111-5317
info@hohance.com
Chemical manufacturer
chemBlink Standard supplier since 2011
Suzhou Myland Pharm & Nutrition Inc. China
www.mylandpharm.com
+86 (512) 6615-0687
+86 (512) 6615-7101
info@mylandpharm.com
QQ Chat
Chemical manufacturer since 2013
chemBlink Standard supplier since 2014
Hangzhou Leap Chem Co., Ltd. China
www.leapchem.com
+86 (571) 8771-1850
market19@leapchem.com
QQ Chat
Chemical manufacturer since 2006
chemBlink Standard supplier since 2015
Amadis Chemical Co., Ltd. China
www.amadischem.com
+86 (571) 8992-5085
+86 (571) 8992-5065
sales@amadischem.com
Chemical manufacturer since 2010
chemBlink Standard supplier since 2015
Hangzhou Hairui Chemical Co., Ltd. China
www.hairuichem.com
+86 (571) 8669-1155
+86 (571) 8669-1154
sales@hairuichem.com
Chemical distributor since 2005
chemBlink Standard supplier since 2017
Zhengzhou Xlinebio Technology Co., Ltd. China
www.xlinebio.com
+86 (371) 6131-8675
+86 (371) 6131-8675
sales@xlinebio.com
Chemical manufacturer since 2017
chemBlink Standard supplier since 2018
Xi'an Yinherb Bio-tech Co., Ltd China
yinherb.ecer.com
+86 (29) 6333-2330
sales@yinherb-nutraceuticals.com
QQ Chat
Chemical manufacturer since 2009
chemBlink Standard supplier since 2021
Wuhan Boye Science And Technology Development Co., Ltd. China
www.boyechemicals.com
+86 (027) 8162-5225
+86 15387090420
+86 (027) 8162-5225
service@boyechemicals.com
QQ Chat
Chemical distributor since 2017
chemBlink Standard supplier since 2022
Shaanxi Greenyo Biotech Co., Ltd. China
www.greenyobio.com
+86 (29) 8177-2657
sales05@greenyobio.com
Chemical distributor since 2017
chemBlink Standard supplier since 2022
Honyan Pharmaceutical (wuhan) Co., Ltd. China
www.hoyanmedicine.com
+86 15832900195
+86 (27) 8233-9698
grace@whhoyan.com
QQ Chat
Skype Chat
WeChat: 008615832900195
WhatsApp:008615832900195
Chemical manufacturer since 2018
chemBlink Standard supplier since 2023
AK Scientific, Inc USA
www.aksci.com
+1 (510) 429-8835
+1 (510) 429-8836
sales@aksci.com
Chemical manufacturer

Identification
ClassificationBiochemical >> Amino acids and their derivatives >> Glycine derivatives
NameN-(1-(Phenylacetyl)-L-prolyl)glycine ethyl ester
Synonymsethyl 2-[[(2S)-1-(2-phenylacetyl)pyrrolidine-2-carbonyl]amino]acetate
Molecular StructureN-(1-(Phenylacetyl)-L-prolyl)glycine ethyl ester molecular structure (CAS 157115-85-0)
Molecular FormulaC17H22N2O4
Molecular Weight318.37
Protein SequencePG
CAS Registry Number157115-85-0
EC Number839-170-3
SMILESCCOC(=O)CNC(=O)[C@@H]1CCCN1C(=O)CC2=CC=CC=C2
Properties
Density1.2±0.1 g/cm3 Calc.*
Boiling point547.3±50.0 °C 760 mmHg (Calc.)*
Flash point284.8±30.1 °C (Calc.)*
Solubility10 mM in DMSO (Expl.)
Index of refraction1.549 (Calc.)*
*Calculated using Advanced Chemistry Development (ACD/Labs) Software.
Safety Data
Hazard Symbolssymbol   GHS07 Warning  Details
Risk StatementsH301-H315-H319-H335  Details
Safety StatementsP261-P301+P312-P302+P362-P304+P340-P305+P351+P338  Details
SDSAvailable
up chemBlink Chemical Story
N-(1-(Phenylacetyl)-L-prolyl)glycine ethyl ester is a synthetic dipeptide-derived compound consisting of a proline–glycine peptide backbone modified at the N-terminus with a phenylacetyl group and at the C-terminal glycine with an ethyl ester. Structurally, it belongs to a class of peptide analogues in which natural amino acid sequences are chemically modified to alter stability, lipophilicity, and metabolic properties.

The core of the molecule is based on a prolyl–glycine dipeptide framework. Proline is a cyclic imino acid whose rigid pyrrolidine ring introduces conformational constraints into peptide structures, often influencing folding and molecular recognition. Glycine, being the smallest amino acid, provides flexibility at the C-terminal region. Together, this combination creates a relatively compact peptide scaffold with both rigidity and flexibility in different segments.

At the N-terminus, the amino group of proline is acylated with a phenylacetyl moiety. The phenylacetyl group consists of a benzene ring connected via a methylene linker to a carbonyl group. This aromatic acyl substitution increases hydrophobicity and introduces π-electron character, which can influence interactions with hydrophobic binding pockets or membranes. The phenyl ring also contributes to steric bulk, which can affect conformational preferences of the peptide backbone.

At the C-terminal end, glycine is present as an ethyl ester rather than a free carboxylic acid. Esterification of the carboxyl group reduces ionic character under physiological conditions and generally increases membrane permeability and lipophilicity. In peptide chemistry, such esterification is commonly used to modify pharmacokinetic behavior by reducing polarity and altering metabolic stability.

The peptide bond between proline and glycine forms the central linkage of the molecule and is characterized by partial double-bond character due to resonance stabilization. This restricts rotation and contributes to defined conformational preferences. The overall conformation of the molecule is influenced by the cyclic nature of proline, the flexibility of glycine, and the steric effects of the N-terminal aromatic substituent.

From a physicochemical standpoint, the molecule contains both hydrophilic and hydrophobic elements. The peptide backbone and carbonyl groups provide polarity and hydrogen-bonding capacity, while the phenyl group and ethyl ester contribute hydrophobic character. This balance often results in moderate solubility in polar organic solvents and limited solubility in water depending on ionization state.

The compound contains multiple sites capable of hydrogen bonding, including amide carbonyls and amide NH groups (where not substituted), which can influence intermolecular interactions and aggregation behavior. However, esterification and N-acylation reduce overall ionic character compared with unmodified peptides.

Without verified literature specific to this exact compound, no claims can be made regarding biological activity, pharmacological function, or therapeutic use. Based on established structural chemistry, it can be reliably described as a phenylacetyl-modified prolyl–glycine dipeptide ethyl ester with mixed hydrophobic and polar characteristics and conformational features influenced primarily by the proline residue and amide linkages.

References

2025. Regulation of Primary Hemostasis by Peptides with Neuroprotective Effect. Neurochemical Journal.
DOI: 10.1134/s181971242570059x

2025. Neuropeptide Cyclo-Prolylglycine: Discovery, Pharmacological Effects, and Mechanism of Action. Neurochemical Journal.
DOI: 10.1134/s1819712425700606

2024. The Influence of the Low-Molecular-Weight NGF Mimetic Dipeptide GK-2 on the Behavior of Mice from Two Outbred Strains That Differ in Brain Weight. Biology Bulletin Reviews.
DOI: 10.1134/s2079086424600346
Market Analysis Reports
Related Products
N2-(2-Phenylace...  N-(Phenylacetyl...  N2-[N-(Phenylac...  N-(Phenylacetyl...  Phenylacetyl Is...  2-O-Phenyl-alph...  N-Phenylacetyl-...  Phenyl 2-Acetyl...  N-(2-Phenylacet...  1-Phenylacetyl-...  3-(2-Phenylacet...  N-(Phenylacetyl...  Phenylacetylure...  10-Phenylacrida...  N-Phenylacridin...  4-Phenyl-9-Acri...  9-Phenylacridin...  Phenyl Acridine...  10-Phenyl-9(10H...  3-Phenylacrylal...